🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨Joanne, Kauê e Iago debatem sobre o manejo no PS da crise álgica aguda em pacientes com Anemia Falciforme. Além da conduta na analgesia, abordamos alguns diagnósticos diferenciais importantes e um guia para casos de dores refratárias e para a prescrição de analgesia domiciliar. Tem alguma dúvida ou sugestão? Mande mensagem no @tadeclinicagem no instagram ou twitter.Referências:1. Goddu, P. et al. Do Words Matter? Stigmatizing Language and the Transmission of Bias in the Medical Record. J GEN INTERN MED 33, 685–691 (2018).2. Haywood C Jr. et al. A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment. J Gen Intern Med. 2011 May;26(5):518-23. Epub 2010 Dec 23.3. Vichinsky E. Evaluation of acute pain in sickle cell disease. Acesso em uptodate.com em outubro/20214. DeBaun M. Acute vaso-occlusive pain management in sickle celldisease. Acesso em uptodate.com em outubro/20215. Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020;4(12):2656-2701.6. Sins JWR, Mager DJ, Davis SCAT, et al. Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review. Blood Adv 2017; 1:1598.7. Brookoff D, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med 1992; 116:364.8. Smith WR, McClish DK, Dahman BA, et al. Daily home opioid use in adults with sickle cell disease: The PiSCES project. J Opioid Manag 2015; 11:243.9. van Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007; 82:955.